Opaleye Management Inc.
CIK 1595855 · Lihat di SEC EDGAR ↗
- Nilai Portofolio
- $1.1B
- Posisi
- 58
- Per tanggal
- 30 Juni 2026
#2.288 dari 9.443 berdasarkan nilai 13F · top 24.2%
Nilai portofolio QoQ: +45.4% 13F tidak mengungkapkan kas
- Bobot 10 kepemilikan teratas
- 64,76%
- Bobot 25 kepemilikan teratas
- 88,49%
- Posisi di atas 1%
- 27
- Jumlah posisi efektif
- 15,3
Berdasarkan kepemilikan ekuitas jangka panjang 13F saja (kas, obligasi, posisi jual tidak diungkapkan)
Perputaran Q2 2026: 10,42% Perkiraan pembelian $156.683.181 · penjualan $97.118.328
Kepemilikan median: 3,0 kuartal Dilacak Q4 2024–Q2 2026 · 52,3% masih dipegang
- Posisi baru
- 13
- Meningkat
- 15
- Menurun
- 13
- Tertutup
- 8
Di halaman ini
- Kinerja vs S&P Bagaimana portofolio 13F manajer ini berkinerja terhadap S&P 500.
- Rincian sektor Bagaimana portofolio terbagi di berbagai sektor pasar.
- Portofolio Setiap saham yang dilaporkan dimiliki oleh institusi ini, dari 13F terbarunya.
- Taruhan Bernilai Tinggi Kepemilikan yang paling terkonsentrasi pada manajer ini.
- Taruhan baru terbesar Posisi baru yang dibuka pada kuartal terakhir.
- Pergerakan Teratas Peningkatan dan penurunan posisi terbesar pada kuartal ini.
- Posisi yang keluar Posisi yang sepenuhnya dijual oleh manajer pada kuartal lalu.
- Terkait Orang di balik pengaju ini, jika kami dapat mencocokkannya.
Kinerja vs S&P 500
Tahunan: +62.6% · S&P 500: +18.0%
Perkiraan portofolio beli-dan-tahan yang dibangun dari snapshot 13F SEC triwulanan. Mengecualikan kas, posisi jual, opsi/derivatif, dan sekuritas non-13(f) — mencerminkan buku ekuitas long yang diungkapkan saja, bukan total AUM dana. Keterlambatan pengajuan SEC hingga 45 hari; ini bukan waktu yang dapat disalin secara real-time.
Cakupan yang dapat dihargai: 96,6% · Opsi dikecualikan: 0,0%
Rincian sektor
Healthcare
99,7%
Lainnya/Tidak terpetakan
0,3%
Portofolio lengkap 58 posisi
| Tipe | Rentetan | Tren 8 kuartal | |||||
|---|---|---|---|---|---|---|---|
| LQDA Liquidia Corporation - Common Stock | $195.139.175 | 17,67% | 2.447.500 | $106.318.675 | Turun ×1 | ||
| ETON Eton Pharmaceuticals, Inc. - Common Stock | $103.532.000 | 9,38% | 2.860.000 | $32.947.200 | |||
| HROW Harrow, Inc. - Common Stock | $101.928.000 | 9,23% | 2.400.000 | $2.063.570 | Turun ×2 | ||
| IRON Disc Medicine, Inc. - Common Stock | $62.534.700 | 5,66% | 855.000 | $35.615.960 | Naik ×5 | ||
| URGN UroGen Pharma Ltd. - Ordinary Shares | $52.991.853 | 4,80% | 1.439.996 | $27.280.453 | Naik ×2 | ||
| APGE Apogee Therapeutics, Inc. - Common Stock | $51.764.700 | 4,69% | 390.000 | $18.938.400 | |||
| MGTX MeiraGTx Holdings plc - Ordinary Shares | $47.960.500 | 4,34% | 3.550.000 | $29.573.077 | Naik ×2 | ||
| SLGL Sol-Gel Technologies Ltd. - Ordinary Shares | $37.070.000 | 3,36% | 500.000 | $-2.540.000 | |||
| RZLT Rezolute, Inc. - Common Stock (NV) | $32.760.000 | 2,97% | 6.300.000 | $13.545.000 | |||
| TGTX TG Therapeutics, Inc. - Common Stock | $29.392.900 | 2,66% | 535.000 | $11.620.200 | |||
| IMMX Immix Biopharma, Inc. - Common Stock | $24.176.950 | 2,19% | 2.345.000 | Naik ×1 | |||
| CBIO Crescent Biopharma, Inc. - Common Stock | $23.748.318 | 2,15% | 1.319.351 | $-364.420 | Naik ×2 | ||
| STOK Stoke Therapeutics, Inc. - Common Stock | $22.904.000 | 2,07% | 700.000 | $112.000 | |||
| ACOG Alpha Cognition Inc. - Common Stock | $20.905.272 | 1,89% | 2.895.467 | $6.840.166 | Naik ×3 | ||
| EWTX Edgewise Therapeutics, Inc. - Common Stock | $20.315.000 | 1,84% | 500.000 | $4.565.000 | |||
| RVMD Revolution Medicines, Inc. - Common Stock | $18.728.000 | 1,70% | 100.000 | $9.003.000 | |||
| GLUE Monte Rosa Therapeutics, Inc. - Common Stock | $18.029.000 | 1,63% | 745.000 | Naik ×1 | |||
| ALMS Alumis Inc. - Common Stock | $15.477.000 | 1,40% | 550.000 | $3.360.500 | |||
| CDXS Codexis, Inc. - Common Stock | $15.334.100 | 1,39% | 6.785.000 | $4.274.550 | |||
| REPL Replimune Group, Inc. - Common Stock | $15.331.873 | 1,39% | 1.384.993 | Naik ×1 | |||
| XOMA XOMA Royalty Corporation - Common Stock | $14.380.895 | 1,30% | 338.374 | $4.969.895 | Naik ×3 | ||
| MBX MBX Biosciences, Inc. - Common Stock | $14.352.000 | 1,30% | 260.000 | $6.591.000 | |||
| RYTM Rhythm Pharmaceuticals, Inc. - Common Stock | $13.601.175 | 1,23% | 122.500 | $-21.722.025 | Turun ×6 | ||
| EDIT Editas Medicine, Inc. - Common Stock | $12.512.653 | 1,13% | 3.861.930 | $7.752.970 | Naik ×1 | ||
| PTGX Protagonist Therapeutics, Inc. - Common Stock | $12.258.000 | 1,11% | 100.000 | $1.718.000 | |||
| CABA Cabaletta Bio, Inc. - Common Stock | $12.016.418 | 1,09% | 3.863.800 | $8.304.218 | Naik ×3 | ||
| QTTB Q32 Bio Inc. - Common Stock | $11.860.940 | 1,07% | 931.000 | $3.795.956 | Turun ×1 | ||
| ANNX Annexon, Inc. - common stock | $9.789.515 | 0,89% | 1.714.451 | $-3.128.441 | Turun ×2 | ||
| VSTM Verastem, Inc. - Common Stock | $6.876.000 | 0,62% | 1.800.000 | Naik ×1 | |||
| ZNTL Zentalis Pharmaceuticals, Inc. - common stock | $6.851.382 | 0,62% | 1.412.656 | $3.545.767 | |||
| RLMD Relmada Therapeutics, Inc. - Common Stock | $6.470.200 | 0,59% | 935.000 | $-37.400 | |||
| OCUL Ocular Therapeutix, Inc. - Common Stock | $5.892.000 | 0,53% | 600.000 | $810.000 | |||
| TRVI Trevi Therapeutics, Inc. - Common Stock | $5.781.500 | 0,52% | 310.000 | $1.664.457 | Turun ×1 | ||
| BBOT BridgeBio Oncology Therapeutics, Inc. - Common Stock | $5.334.000 | 0,48% | 700.000 | $4.857.126 | Naik ×1 | ||
| LYEL Lyell Immunopharma, Inc. - Common Stock | $4.833.551 | 0,44% | 344.025 | $3.246.865 | Naik ×1 | ||
| IRD Opus Genetics, Inc. - Common Stock | $4.623.750 | 0,42% | 1.125.000 | $2.372.550 | Naik ×1 | ||
| FDMT 4D Molecular Therapeutics, Inc. - Common Stock | $4.448.012 | 0,40% | 334.437 | $3.402.583 | Naik ×1 | ||
| NTLA Intellia Therapeutics, Inc. - Common Stock | $4.230.000 | 0,38% | 250.000 | $1.089.100 | Naik ×1 | ||
| VYGR Voyager Therapeutics, Inc. - Common Stock | $4.147.500 | 0,38% | 1.185.000 | $-291.500 | Naik ×1 | ||
| BDSX Biodesix, Inc. - Common Stock | $4.059.000 | 0,37% | 180.000 | $607.318 | Turun ×1 | ||
| RCKT Rocket Pharmaceuticals, Inc. - Common Stock | $3.420.000 | 0,31% | 1.000.000 | $1.100 | Naik ×1 | ||
| JBIO Jade Biosciences, Inc. - Common Stock | $3.221.900 | 0,29% | 145.000 | $-2.785.992 | Turun ×1 | ||
| SNWV SANUWAVE Health, Inc. - Common Stock | $3.061.400 | 0,28% | 306.140 | $-13.904.706 | Turun ×1 | ||
| FBIO Fortress Biotech, Inc. - Common Stock | $2.723.400 | 0,25% | 890.000 | $-183.780 | Turun ×2 | ||
| DERM Journey Medical Corporation - Common Stock | $2.478.000 | 0,22% | 350.000 | $-2.024.400 | Turun ×2 | ||
| PHAT Phathom Pharmaceuticals, Inc. - Common Stock | $2.013.641 | 0,18% | 185.589 | Naik ×1 | |||
| INBX Inhibrx Biosciences, Inc. - Common Stock | $1.922.572 | 0,17% | 20.291 | Naik ×1 | |||
| ENTA Enanta Pharmaceuticals, Inc. - Common Stock | $1.822.500 | 0,17% | 125.000 | $243.750 | |||
| Penerbit tidak dikenal (CUSIP: 423494103) | $1.750.258 | 0,16% | 47.652 | Naik ×1 | |||
| Penerbit tidak dikenal (CUSIP: 337185102) | $1.307.800 | 0,12% | 65.000 | Naik ×1 | |||
| CGON CG Oncology, Inc. - Common stock | $1.263.908 | 0,11% | 17.789 | $-5.152.156 | Turun ×2 | ||
| BHVN Biohaven Ltd. Common Shares | $1.159.375 | 0,10% | 77.915 | Naik ×1 | |||
| AVIR Atea Pharmaceuticals, Inc. - common stock | $1.092.750 | 0,10% | 235.000 | $-642.838 | Turun ×1 | ||
| KTTA Pasithea Therapeutics Corp. - Common Stock | $1.056.570 | 0,10% | 2.050.000 | Naik ×1 | |||
| ADCT ADC Therapeutics SA Common Shares | $749.000 | 0,07% | 700.000 | ||||
| OKYO OKYO Pharma Limited - Ordinary Shares | $562.806 | 0,05% | 375.204 | Naik ×1 | |||
| PTN Palatin Technologies, Inc. - Common Stock | $221.195 | 0,02% | 20.500 | Naik ×1 | |||
| ADGM Adagio Medical Holdings, Inc - Common Stock | $13.353 | 0,00% | 18.444 | $-7.858 | |||
| Tidak ada hasil | |||||||
Kepemilikan dengan keyakinan
Posisi meningkat selama 3+ kuartal berturut-turut.
Jumlah saham dilaporkan dalam pengajuan 13F (tidak disesuaikan split)
Taruhan baru terbesar
Posisi baru dibuka kuartal ini, terbesar diurutkan pertama.
| Sekuritas | Nilai | Saham | % dari portofolio |
|---|---|---|---|
| IMMX | $24.176.950 | 2.345.000 | 2,19% |
| GLUE | $18.029.000 | 745.000 | 1,63% |
| REPL | $15.331.873 | 1.384.993 | 1,39% |
| VSTM | $6.876.000 | 1.800.000 | 0,62% |
| PHAT | $2.013.641 | 185.589 | 0,18% |
| INBX | $1.922.572 | 20.291 | 0,17% |
| Penerbit tidak dikenal (CUSIP: 423494103) | $1.750.258 | 47.652 | 0,16% |
| Penerbit tidak dikenal (CUSIP: 337185102) | $1.307.800 | 65.000 | 0,12% |
| BHVN | $1.159.375 | 77.915 | 0,10% |
| KTTA | $1.056.570 | 2.050.000 | 0,10% |
| ADCT | $749.000 | 700.000 | 0,07% |
| OKYO | $562.806 | 375.204 | 0,05% |
| PTN | $221.195 | 20.500 | 0,02% |
Penggerak teratas (QoQ)
| Sekuritas | Aksi | Saham Δ | Nilai Δ |
|---|---|---|---|
| LQDA | Dipangkas | -98K | +$106.3M |
| IRON | Beli lebih banyak | +434K | +$35.6M |
| ETON | Hanya pergerakan harga | +0 | +$32.9M |
| MGTX | Beli lebih banyak | +1.4M | +$29.6M |
| URGN | Beli lebih banyak | +10K | +$27.3M |
| RYTM | Dipangkas | -500 | -$21.7M |
| APGE | Hanya pergerakan harga | +0 | +$18.9M |
| RZLT | Hanya pergerakan harga | +0 | +$13.5M |
| TGTX | Hanya pergerakan harga | +0 | +$11.6M |
| RVMD | Hanya pergerakan harga | +0 | +$9.0M |
1 posisi disembunyikan (pemeriksaan kelengkapan data)
Posisi yang keluar
Termasuk peristiwa perusahaan (merger, delisting) — tidak semua keluar adalah penjualan
Posisi tertutup mencerminkan perubahan pelaporan 13F; bagi manajer indeks, ini sering kali mekanis (penghapusan pencatatan, M&A, penyeimbangan ulang indeks), bukan keputusan aktif.
| Sekuritas | Kuartal | Saham sebelumnya | Nilai sebelumnya | Harga sejak keluar |
|---|---|---|---|---|
| IMNM | 31 Des. 2025 | 3.185.000 | $37.296.350 | 33,1% |
| CATX | 30 Juni 2026 | 4.675.000 | $19.494.750 | Tidak lagi dilacak |
| ALKS | 31 Maret 2026 | 490.000 | $13.710.200 | 39,5% |
| SRPT | 31 Des. 2025 | 585.000 | $11.272.950 | -11,0% |
| LRMR | 31 Des. 2025 | 3.720.867 | $10.564.900 | 8,0% |
| JSPR | 31 Maret 2025 | 400.000 | $8.552.000 | -82,6% |
| GOSS | 31 Maret 2026 | 2.720.000 | $8.432.000 | -52,8% |
| ARVN | 31 Des. 2025 | 987.818 | $8.416.209 | -20,2% |
| NAMS | 31 Maret 2025 | 325.000 | $8.352.500 | 36,6% |
| VIGL | 30 Sep. 2025 | 1.000.000 | $7.950.000 | Tidak lagi dilacak |
| KPTI | 31 Maret 2026 | 930.000 | $6.844.800 | -65,5% |
| ANIK | 30 Sep. 2025 | 588.797 | $6.229.472 | 126,2% |
| PCVX | 31 Maret 2025 | 75.000 | $6.139.500 | 63,1% |
| DNA | 30 Sep. 2025 | 500.000 | $5.625.000 | -48,0% |
| ASRT | 30 Juni 2026 | 265.707 | $5.064.375 | Tidak lagi dilacak |
| PVLA | 30 Juni 2025 | 172.357 | $4.824.272 | 539,9% |
| STRO | 30 Juni 2026 | 190.671 | $4.749.615 | -36,3% |
| TMCI | 31 Des. 2025 | 702.245 | $4.712.064 | 79,2% |
| ANAB | 30 Juni 2025 | 250.933 | $4.664.844 | 161,7% |
| NUVL | 31 Maret 2025 | 58.500 | $4.579.380 | Tidak lagi dilacak |
| SLRN | 30 Juni 2025 | 1.615.000 | $3.989.050 | Tidak lagi dilacak |
| TECX | 30 Juni 2026 | 123.000 | $3.801.930 | 5,2% |
| EPIX | 30 Sep. 2025 | 2.209.998 | $3.756.997 | Tidak lagi dilacak |
| ZYME | 31 Maret 2026 | 108.929 | $2.868.101 | 6,5% |
| ABCL | 31 Maret 2025 | 965.000 | $2.827.450 | 426,5% |
| CRGX | 30 Sep. 2025 | 666.503 | $2.745.992 | Tidak lagi dilacak |
| ADCT | 31 Des. 2025 | 682.529 | $2.730.116 | -70,6% |
| TARA | 30 Sep. 2025 | 855.000 | $2.590.650 | -10,1% |
| URGN | 31 Maret 2025 | 220.000 | $2.343.000 | 343,9% |
| VTYX | 31 Maret 2026 | 251.932 | $2.274.946 | Tidak lagi dilacak |
| RCEL | 30 Sep. 2025 | 389.519 | $2.060.556 | 99,6% |
| BDSXXXXX | 30 Juni 2025 | 3.225.000 | $2.016.270 | Tidak lagi dilacak |
| RIGL | 30 Juni 2026 | 70.000 | $1.892.800 | 15,8% |
| OPTN | 30 Juni 2025 | 193.039 | $1.770.168 | Tidak lagi dilacak |
| GBIO | 31 Maret 2026 | 310.000 | $1.760.800 | Tidak lagi dilacak |
| NXTC | 30 Juni 2026 | 141.181 | $1.507.813 | 306,3% |
| BBIO | 31 Maret 2026 | 18.319 | $1.401.220 | 12,1% |
| KNSA | 30 Juni 2025 | 62.501 | $1.388.147 | 187,9% |
| NRIX | 30 Juni 2025 | 115.000 | $1.366.200 | 136,8% |
| IMTX | 31 Maret 2025 | 165.000 | $1.173.150 | 94,7% |
| SYRE | 31 Des. 2025 | 65.000 | $1.089.400 | 223,4% |
| LXEO | 31 Maret 2025 | 130.000 | $855.400 | 50,1% |
| PLX | 30 Juni 2026 | 340.000 | $737.800 | Tidak lagi dilacak |
| SGMO | 30 Juni 2025 | 1.055.000 | $691.869 | Tidak lagi dilacak |
| RGNX | 31 Maret 2025 | 80.000 | $618.400 | 59,5% |
| ELEV | 30 Sep. 2025 | 1.442.061 | $529.381 | Tidak lagi dilacak |
| SLN | 31 Maret 2026 | 78.926 | $479.870 | 150,7% |
| LBRX | 30 Juni 2026 | 14.506 | $357.718 | 48,8% |
| PEPG | 31 Des. 2025 | 75.000 | $346.500 | -52,1% |
| IBIO | 31 Des. 2025 | 375.000 | $310.425 | -24,9% |
| VTYX | 30 Juni 2025 | 190.000 | $218.500 | Tidak lagi dilacak |
| RAPT | 31 Maret 2026 | 150.000 | $213.363 | Tidak lagi dilacak |